{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:41:47Z","timestamp":1790757707161,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA101318"],"award-info":[{"award-number":["R01 CA101318"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA087845"],"award-info":[{"award-number":["R01 CA087845"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R25 CA117865)"],"award-info":[{"award-number":["R25 CA117865)"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA082709"],"award-info":[{"award-number":["P30 CA082709"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["UL1 RR025761"],"award-info":[{"award-number":["UL1 RR025761"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["C06RR020128"],"award-info":[{"award-number":["C06RR020128"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["S10RR027710"],"award-info":[{"award-number":["S10RR027710"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01 AG019771"],"award-info":[{"award-number":["R01 AG019771"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P30 AG010133"],"award-info":[{"award-number":["P30 AG010133"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00520-016-3329-5","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T05:23:52Z","timestamp":1469683432000},"page":"4779-4789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment"],"prefix":"10.1007","volume":"24","author":[{"given":"Noah R.","family":"Zanville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly N. H.","family":"Nudelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dori J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Von Ah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna C.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"issue":"Suppl 3","key":"3329_CR1","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/1471-2458-14-S3-S8","volume":"14","author":"T Islam","year":"2014","unstructured":"Islam T et al. (2014) Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health 14(Suppl 3):S8","journal-title":"BMC Public Health"},{"issue":"2","key":"3329_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pon.585","volume":"11","author":"ER Spelten","year":"2002","unstructured":"Spelten ER, Sprangers MA, Verbeek JH (2002) Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology 11(2):124\u2013131","journal-title":"Psychooncology"},{"issue":"2","key":"3329_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5271\/sjweh.3199","volume":"38","author":"SJ Tamminga","year":"2012","unstructured":"Tamminga SJ et al. (2012) Breast cancer survivors\u2019 views of factors that influence the return-to-work process\u2014a qualitative study. Scand J Work Environ Health 38(2):144\u2013154","journal-title":"Scand J Work Environ Health"},{"issue":"3","key":"3329_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10549-008-0209-9","volume":"116","author":"E Ahn","year":"2009","unstructured":"Ahn E et al. (2009) Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat 116(3):609\u2013616","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3329_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1365-2354.2011.01291.x","volume":"20","author":"M Banning","year":"2011","unstructured":"Banning M (2011) Employment and breast cancer: a meta-ethnography. Eur J Cancer Care (Engl) 20(6):708\u2013719","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"1","key":"3329_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jhealeco.2004.07.003","volume":"24","author":"CJ Bradley","year":"2005","unstructured":"Bradley CJ et al. (2005) Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ 24(1):137\u2013160","journal-title":"J Health Econ"},{"key":"3329_CR7","unstructured":"Mahon, S.M., et al. (2011) Breast cancer, in Site specific series, S.M. Mohan, Editor. Oncology Nursing Society. 248"},{"key":"3329_CR8","unstructured":"de Boer, A.G., et al. (2011) Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev (2): p. CD007569"},{"issue":"3","key":"3329_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00520-011-1141-9","volume":"20","author":"SL Wolf","year":"2012","unstructured":"Wolf SL et al. (2012) The relationship between numbness, tingling, and shooting\/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer 20(3):625\u2013632","journal-title":"Support Care Cancer"},{"issue":"18","key":"3329_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL et al. (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(18):1941\u20131967","journal-title":"J Clin Oncol"},{"key":"3329_CR11","doi-asserted-by":"crossref","unstructured":"Mols, F., et al. (2014) Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer","DOI":"10.1007\/s00520-014-2255-7"},{"issue":"4","key":"3329_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00520-011-1336-0","volume":"20","author":"CM Driessen","year":"2012","unstructured":"Driessen CM et al. (2012) Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure. Support Care Cancer 20(4):877\u2013881","journal-title":"Support Care Cancer"},{"issue":"3","key":"3329_CR13","first-page":"773","volume":"40","author":"B Sorbe","year":"2012","unstructured":"Sorbe B et al. (2012) A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: neurological toxicity and quality-of-life evaluation. Int J Oncol 40(3):773\u2013781","journal-title":"Int J Oncol"},{"key":"3329_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/2193-1801-3-366","volume":"3","author":"B Bhatnagar","year":"2014","unstructured":"Bhatnagar B et al. (2014) Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springerplus 3:366","journal-title":"Springerplus"},{"issue":"5","key":"3329_CR15","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","volume":"9","author":"RM Speck","year":"2013","unstructured":"Speck RM et al. (2013) Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer. J Oncol Pract 9(5):e234\u2013e240","journal-title":"J Oncol Pract"},{"issue":"1\u20132","key":"3329_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","volume":"109","author":"PM Dougherty","year":"2004","unstructured":"Dougherty PM et al. (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109(1\u20132):132\u2013142","journal-title":"Pain"},{"issue":"3","key":"3329_CR17","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1188\/10.CJON.E22-E28","volume":"14","author":"C Tofthagen","year":"2010","unstructured":"Tofthagen C (2010) Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 14(3):E22\u2013E28","journal-title":"Clin J Oncol Nurs"},{"key":"3329_CR18","unstructured":"United States Department of Labor ( 2016) Labor force by sex, 2014 and projected 2022. [cited 2016 April 25]; Available from: \n                    http:\/\/www.dol.gov\/wb\/stats\/laborforce_sex_projected_2014_2022_txt.htm"},{"key":"3329_CR19","unstructured":"American Cancer Society (2016) Facts and figures, A.C. Society, Editor. Atlanta"},{"issue":"1","key":"3329_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/07357900601130664","volume":"25","author":"CJ Bradley","year":"2007","unstructured":"Bradley CJ et al. (2007) Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Investig 25(1):47\u201354","journal-title":"Cancer Investig"},{"issue":"1","key":"3329_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1300\/J013v36n01_01","volume":"36","author":"TN Chirikos","year":"2002","unstructured":"Chirikos TN, Russell-Jacobs A, Jacobsen PB (2002) Functional impairment and the economic consequences of female breast cancer. Women Health 36(1):1\u201320","journal-title":"Women Health"},{"issue":"1","key":"3329_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1005805907311","volume":"35","author":"PA Forsyth","year":"1997","unstructured":"Forsyth PA et al. (1997) Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neuro-Oncol 35(1):47\u201353","journal-title":"J Neuro-Oncol"},{"key":"3329_CR23","doi-asserted-by":"crossref","unstructured":"Park, S.B., et al. (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin","DOI":"10.3322\/caac.21204"},{"issue":"9","key":"3329_CR24","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1007\/s00415-012-6442-5","volume":"259","author":"K Osmani","year":"2012","unstructured":"Osmani K et al. (2012) Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation. J Neurol 259(9):1936\u20131943","journal-title":"J Neurol"},{"key":"3329_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2407-6-5","volume":"6","author":"S Pignata","year":"2006","unstructured":"Pignata S et al. (2006) Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in ovarian cancer (MITO-4) retrospective study. BMC Cancer 6:5","journal-title":"BMC Cancer"},{"issue":"3","key":"3329_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","volume":"125","author":"DL Hershman","year":"2011","unstructured":"Hershman DL et al. (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767\u2013774","journal-title":"Breast Cancer Res Treat"},{"key":"3329_CR27","doi-asserted-by":"crossref","unstructured":"Smith, E.M., et al. (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial, in JAMA. United States. 1359\u201367","DOI":"10.1001\/jama.2013.2813"},{"key":"3329_CR28","doi-asserted-by":"crossref","unstructured":"Tanay, M.A., J. Armes, and E. Ream (2016) The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis. Eur J Cancer Care (Engl)","DOI":"10.1111\/ecc.12443"},{"key":"3329_CR29","first-page":"913848","volume":"2012","author":"CT Pike","year":"2012","unstructured":"Pike CT et al. (2012) Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother Res Pract 2012:913848","journal-title":"Chemother Res Pract"},{"issue":"5","key":"3329_CR30","doi-asserted-by":"publisher","first-page":"e96713","DOI":"10.1371\/journal.pone.0096713","volume":"9","author":"KN Nudelman","year":"2014","unstructured":"Nudelman KN et al. (2014) Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. PLoS One 9(5):e96713","journal-title":"PLoS One"},{"issue":"7","key":"3329_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1200\/JCO.2015.62.1276","volume":"34","author":"KN Nudelman","year":"2016","unstructured":"Nudelman KN et al. (2016) Cerebral perfusion and gray matter changes associated with chemotherapy-induced peripheral neuropathy. J Clin Oncol 34(7):677\u2013683","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"3329_CR32","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","volume":"30","author":"BC McDonald","year":"2013","unstructured":"McDonald BC et al. (2013) Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun 30(Suppl):S117\u2013S125","journal-title":"Brain Behav Immun"},{"key":"3329_CR33","unstructured":"Smith, E.M. (2013) Current methods for the assessment and management of taxane-related neuropathy, in Clin J Oncol Nurs. United States. 22\u201334"},{"issue":"2","key":"3329_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1525-1438.2007.00794.x","volume":"17","author":"HQ Huang","year":"2007","unstructured":"Huang HQ et al. (2007) Validation and reduction of FACT\/GOG-Ntx subscale for platinum\/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study. Int J Gynecol Cancer 17(2):387\u2013393","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"3329_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1529-8027.2010.00292.x","volume":"15","author":"KA Griffith","year":"2010","unstructured":"Griffith KA et al. (2010) Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties. J Peripher Nerv Syst 15(4):314\u2013325","journal-title":"J Peripher Nerv Syst"},{"issue":"11","key":"3329_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.12788\/jcso.0086","volume":"12","author":"A Beijers","year":"2014","unstructured":"Beijers A et al. (2014) Chemotherapy-induced peripheral neuropathy and impact on quality of life 6\u00a0months after treatment with chemotherapy. J Community Support Oncol 12(11):401\u2013406","journal-title":"J Community Support Oncol"},{"issue":"5","key":"3329_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","volume":"16","author":"SB Park","year":"2011","unstructured":"Park SB et al. (2011) Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. Oncologist 16(5):708\u2013716","journal-title":"Oncologist"},{"issue":"6","key":"3329_CR38","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1525-1438.2003.13603.x","volume":"13","author":"EA Calhoun","year":"2003","unstructured":"Calhoun EA et al. (2003) Psychometric evaluation of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group\u2013Neurotoxicity (FACT\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer 13(6):741\u2013748","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"3329_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00520-008-0550-x","volume":"17","author":"K Kuroi","year":"2009","unstructured":"Kuroi K et al. (2009) Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study). Support Care Cancer 17(8):1071\u20131080","journal-title":"Support Care Cancer"},{"issue":"12","key":"3329_CR40","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00415-005-0887-8","volume":"252","author":"AA Argyriou","year":"2005","unstructured":"Argyriou AA et al. (2005) Paclitaxel plus carboplatin-induced peripheral neuropathy. A prospective clinical and electrophysiological study in patients suffering from solid malignancies. J Neurol 252(12):1459\u20131464","journal-title":"J Neurol"},{"key":"3329_CR41","doi-asserted-by":"crossref","unstructured":"Bakitas, M.A. (2007) Background noise: the experience of chemotherapy-induced peripheral neuropathy, in Nurs Res. United States. 323\u201331","DOI":"10.1097\/01.NNR.0000289503.22414.79"},{"issue":"1","key":"3329_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jpainsymman.2011.03.015","volume":"43","author":"G Marineo","year":"2012","unstructured":"Marineo G et al. (2012) Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manag 43(1):87\u201395","journal-title":"J Pain Symptom Manag"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3329-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:26:39Z","timestamp":1589642799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3329-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["3329"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3329-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]},"assertion":[{"value":"4 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose. The authors verify that they have full control of all primary data and agree, if requested, to allow the journal to verify the data from which all analyses were derived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}